Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer.
Wang Z, Zhang Q, Qi C, Bai Y, Zhao F, Chen H, Li Z, Wang X, Chen M, Gong J, Peng Z, Zhang X, Cai J, Chen S, Zhao X, Shen L, Li J.
Wang Z, et al. Among authors: cai j.
J Immunother Cancer. 2022 Jun;10(6):e004703. doi: 10.1136/jitc-2022-004703.
J Immunother Cancer. 2022.
PMID: 35705314
Free PMC article.